• Western Secondary Antibody Dilution Buffer: Enhancing Wester

  2026-06-11

  The Western Secondary Antibody Dilution Buffer from APExBIO delivers robust signal clarity and supports multiple reuses of diluted antibodies, streamlining Western blot workflows. This article translates recent atherosclerosis assay protocols and troubleshooting insights into actionable strategies for improving protein detection reliability.

• Ricin-Induced Necroptosis in Lung Epithelium: Mechanisms and

  2026-06-10

  Kempen et al. uncover how ricin toxin exposure provokes necroptosis in lung epithelial cells through a bystander effect driven by inflammatory mediators released from dying monocytes. This work advances understanding of toxin-mediated lung injury and offers new directions for dissecting inflammatory cell death pathways in respiratory disease models.

• L1023 Anti-Cancer Compound Library: Precision in Oncology Sc

  2026-06-10

  The L1023 Anti-Cancer Compound Library accelerates biomarker-driven oncology discovery with validated, pathway-selective agents. Leveraging high-throughput screening and rigorous quality control, this resource empowers researchers to dissect complex oncogenic networks and streamline novel inhibitor identification.

• Benzyl-activated Streptavidin Magnetic Beads: Mechanistic Fo

  2026-06-09

  Explore the mechanistic principles and advanced research applications of Benzyl-activated Streptavidin Magnetic Beads. This article uniquely connects core biochemical properties to practical assay design, offering new insight for molecular biology and virology workflows.

• TLR4 Regulation of TF-Positive Extracellular Vesicles in End

  2026-06-09

  Sachetto et al. provide new mechanistic evidence that Toll-like receptor 4 (TLR4) is the principal regulator of tissue factor (TF)-positive extracellular vesicle (EV) release and subsequent coagulation activation during endotoxemia in mice. Their systematic use of genetic knockouts and selective inhibitors clarifies the distinct contributions of TLR4, caspase-11, and the NLRP3 inflammasome, refining our understanding of inflammatory and coagulatory crosstalk in sepsis models.

• (S)-(+)-Ibuprofen: Precision Inhibition and Translational In

  2026-06-08

  (S)-(+)-Ibuprofen is a leading COX inhibitor for advanced inflammation pathway research. Explore its mechanism, selectivity, and experimental impact—plus actionable protocols and critical innovations that set this enantiomer apart.

• Sodium Dicloxacillin Monohydrate: Advanced Workflows for MSS

  2026-06-08

  Sodium dicloxacillin monohydrate offers precise, pH-responsive bactericidal activity and reproducible PK/PD performance against methicillin-sensitive Staphylococcus aureus (MSSA). This article delivers practical experimental workflows, critical troubleshooting strategies, and a translational bridge from in vitro to in vivo applications, empowering researchers to optimize Gram-positive bacterial infection models.

• Methylprednisolone Sodium Succinate in Cell Assays: Bench-Pr

  2026-06-07

  This article addresses common laboratory challenges in cell viability and immunology experiments, demonstrating how Methylprednisolone Sodium Succinate (SKU B4953) from APExBIO delivers reproducible, data-backed performance. Scenario-driven Q&A blocks provide actionable insights for protocol optimization, vendor selection, and reliable data interpretation.

• Optimizing SUMOylation Inhibition with 2-D08 (2’,3’,4’-trihy

  2026-06-06

  This article delivers evidence-based guidance on leveraging 2-D08 (2’,3’,4’-trihydroxyflavone) (SKU C4445) for reliable, reproducible sumoylation inhibition in cell-based assays. Practical scenarios illustrate how this posttranslational modification inhibitor addresses common lab challenges in cancer cell line studies and mitochondrial quality control.

• Transforming Membrane Protein Science with n-Dodecyl-β-D-mal

  2026-06-05

  This article explores the pivotal role of n-Dodecyl-β-D-maltoside (DDM) in the solubilization, purification, and mechanistic study of challenging membrane proteins such as Mycobacterium tuberculosis WecA. Integrating mechanistic insights, protocol recommendations, and strategic guidance, it offers translational researchers a roadmap for leveraging DDM to accelerate drug discovery, with context from recent literature and a focus on practical, evidence-based workflow optimization.

• Viral Control of RIPK3 Degradation Regulates Inflammation an

  2026-06-05

  This study identifies a class of viral proteins that induce the ubiquitin-proteasome-mediated degradation of RIPK3, a key necroptosis adaptor. By elucidating how orthopoxviruses exploit this pathway to modulate host inflammation and viral replication, the findings provide a mechanistic basis for future research on immune evasion and antiviral strategies.

• Parathyroid Hormone (1-34) (Human): Precision in Bone Metabo

  2026-06-04

  Parathyroid hormone (1-34) (human) from APExBIO enables high-fidelity modeling of calcium homeostasis, bone metabolism, and endothelial signaling in translational research. This article dissects experimental workflows, troubleshooting, and advanced applications that leverage this potent peptide fragment for robust, reproducible results.

• ER-Targeted Peptide Self-Assembly Modulates Cancer Cell Fate

  2026-06-04

  The referenced study introduces a peptide system engineered for the endoplasmic reticulum (ER), leveraging enzyme-instructed self-assembly (EISA) for selective induction of apoptosis and necroptosis in cancer cells. This approach overcomes prior concentration-dependent limitations and offers a refined strategy for organelle-targeted cancer therapy.

• Ruxolitinib Phosphate Induces Mitochondrial-Dependent Cell D

  2026-06-03

  This study reveals that Ruxolitinib phosphate (INCB018424) triggers apoptosis and GSDME-mediated pyroptosis in anaplastic thyroid carcinoma by inhibiting DRP1-driven mitochondrial fission through JAK1/2-STAT3 pathway blockade. These findings highlight a novel mechanism for JAK/STAT signaling pathway modulation in aggressive thyroid malignancy and offer new research directions for targeting mitochondrial dynamics in solid tumors.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-03

  Xue et al. provide the first rigorous investigation of sex differences in angiotensin II-induced hypertension in conscious mice, revealing that male mice develop more severe hypertension than females following chronic angiotensin II infusion. The study also demonstrates the modulatory role of sex hormones and altered baroreflex function, highlighting the importance of including sex as a biological variable in cardiovascular research models.

406 records 12/28 page Previous Next First page 上5页 1112131415 下5页 Last page